[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 29,833
Sort by:
Drug Discovery Outsourcing (DDO) Global Market – Forecast To 2030 US$ 7,200.00

... all segments, global trends and emerging strategies of the outsourcing market related to drug discovery. Major Drug Discovery Outsourcing (DDO) players included in the report are Evotec, Charles ...

May 2021 238 pages
North America: Vitamins Market US$ 1,999.00

... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...

May 2021 150 pages
Global Antibiotics Partnering Terms and Agreements 2010 to 2021 US$ 3,495.00

... healthcare sectors, covering: Antibiotics Aminoglycosides Cephalosporin Clindamycin Macrolides Penicillin Quinolones Sulfonamides Tetracycline Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into ...

May 2021 300 pages
Global Vaccine Partnering Terms and Agreements 2014-2020: Deal trends, players and financials US$ 3,495.00

... by the big pharma and big biotech companies of the world in terms of deals made. One of the key highlights of the report is that over 450 online deals records of actual vaccine deals ...

May 2021 550 pages
Anthrax - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Anthrax - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anthrax development. The report provides detailed ...

May 2021 60 pages
Aplastic Anemia - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Aplastic Anemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Aplastic Anemia development. The report provides ...

May 2021 60 pages
Bacteremia - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Bacteremia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bacteremia development. The report provides detailed ...

May 2021 60 pages
Diabetic gastroparesis - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Diabetic Gastroparesis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Gastroparesis development. The report provides ...

May 2021 70 pages
Gastrointestinal Stromal Tumors - Pipeline Insight, 2021 US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Gastrointestinal Stromal Tumor (GIST) The report also ...

May 2021 60 pages
Bacterial vaginosis - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Bacterial Vaginosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bacterial Vaginosis development. The report provides ...

May 2021 60 pages
Hepatitis D - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Hepatitis D - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatitis D development. The report provides ...

May 2021 60 pages
Hyperphosphatemia - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Hyperphosphatemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hyperphosphatemia development. The report provides detailed ...

May 2021 60 pages
Influenza A virus H5N1 subtype - Pipeline Insight, 2021 US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Influenza A Infections The report also ...

May 2021 60 pages
Nocturia - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Nocturia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nocturia development. The report provides detailed ...

May 2021 60 pages
Open-angle glaucoma - Pipeline Insight, 2021 US$ 2,000.00

... clients within 72 Hours 'Open-Angle Glaucoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Open-Angle Glaucoma development. The report provides ...

May 2021 80 pages
Paroxysmal nocturnal haemoglobinuria - Pipeline Insight, 2021 US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Paroxysmal Nocturnal Hemoglobinuria The report also ...

May 2021 100 pages
Peripheral Arterial Disease - Pipeline Insight, 2021 US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) The report also ...

May 2021 60 pages
Postmenopausal osteoporosis - Pipeline Insight, 2021 US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Post Menopausal Osteoporosis The report also ...

May 2021 60 pages
Retinitis Pigmentosa - Pipeline Insight, 2021 US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Retinitis Pigmentosa (Retinitis) The report also ...

May 2021 80 pages
Tinnitus - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Tinnitus - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Tinnitus development. The report provides detailed ...

May 2021 60 pages
Nontuberculous Mycobacteria (NTM) Infections - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Nontuberculous Mycobacteria (NTM) Infections - Pipeline Insight, 2021,” report provides comprehensive insights about 14+...

May 2021 60 pages
Chagas disease - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Chagas disease – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs...

May 2021 60 pages
Irritable bowel syndrome - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Irritable bowel syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 24+ companies and 24+ pi...

May 2021 60 pages
Leigh disease - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Leigh disease - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...

May 2021 60 pages
Methicillin-Resistant Staphylococcus Aureus Infections - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Methicillin-Resistant Staphylococcus Aureus Infections - Pipeline Insight, 2021,” report provides comprehensive insights...

May 2021 60 pages
Pneumococcal infections - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Pneumococcal infections – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pip...

May 2021 60 pages
Polycystic ovary syndrome - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Polycystic ovary syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pip...

May 2021 60 pages
Pyoderma gangrenosum - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Pyoderma gangrenosum - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...

May 2021 60 pages
Vasomotor Symptoms - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Vasomotor Symptoms - Pipeline Insight, 2021,” report provides comprehensive insights about 9+ companies and 9+ pipeline d...

May 2021 60 pages
Acute Ischemic Stroke - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Acute Ischemic Stroke – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipel...

May 2021 60 pages
Adenovirus infections - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Adenovirus infections – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipelin...

May 2021 60 pages
Anti-CD20 antibody - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Anti-CD20 antibody – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline...

May 2021 60 pages
Atherosclerosis - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Atherosclerosis – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline dr...

May 2021 60 pages
BK Virus infections - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “BK Virus infections – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...

May 2021 60 pages
Chronic hand eczema - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic hand eczema - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...

May 2021 60 pages
Gilles de la Tourette’s syndrome US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Gilles de la Tourette’s syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and...

May 2021 60 pages
Hemophilia A - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Hemophilia A - Pipeline Insight, 2021,” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs...

May 2021 80 pages
Hidradenitis Suppurativa - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Hidradenitis Suppurativa - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pi...

May 2021 70 pages
HR+/ HER2-VE Breast Cancer - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “HR+/ HER2-VE Breast Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+...

May 2021 70 pages
Lipodystrophy - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Lipodystrophy – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drug...

May 2021 60 pages
Methylmalonic academia - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Methylmalonic academia - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...

May 2021 60 pages
Middle East respiratory syndrome - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Middle East respiratory syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...

May 2021 60 pages
Neutropenia - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Neutropenia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 30+ pipeline drugs...

May 2021 60 pages
Sialorrhoea - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sialorrhoea – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in...

May 2021 60 pages
Sleep apnoea syndrome - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sleep apnoea syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipel...

May 2021 60 pages
Tendinitis - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Tendinitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in...

May 2021 60 pages
Vertigo - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Vertigo - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Ver...

May 2021 60 pages
Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Drugs in Development, 2021 US$ 3,000.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) development ...

April 2021 60 pages
Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase or Aminopeptidase M or Microsomal Aminopeptidase or gp150 or CD13 or ANPEP or EC 3.4.11.2) - Drugs in Development, 2021 US$ 3,000.00

... players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase or Aminopeptidase M or Microsomal Aminopeptidase or gp150 or CD13 or ANPEP or EC 3.4.11.2) development ...

April 2021 35 pages

Filters

Search

Categories

891
21,100
7,682
114
46

Publishers

5
1
22
292
33
73
4
8
50
63
180
12
3,838
142
95
363
322
3
25
84
6
8
11
14
4
46
37
1
1
1,818
12
579
11
1,998
7
24
5,320
38
31
54
216
1,283
40
34
8
37
46
43
50
2,538
210
40
26
7
6
2
4
26
15
695
3,346
2,222
11
22
1
15
37
228
2
7
10
4
59
4
19
29
1
5
6
2
2
32
2
13
17
1
11
109
36
1
15
12
143
172
6
4
2
1
4
5
4
9
1
56
12
18
50
33
1
26
16
1
2
1
42
118
55
14
18
1
243
597
569
2
1
2
5
88
63
59
35
41
22
2
14
5
23
2
2

Regions

9
1,366
103
89
63
57
56
54
34
32
30
29
28
27
26
25
24
24
23
23
23
22
22
22
22
22
22
21
21
21
21
20
20
20
19
19
19
19
18
18
18
18
17
17
17
16
16
15
15
14
13
11
11
11
10
8
5
16
15
13
13
11
9
6
5
3
2
1
27
13
7
15
5
5
7
10
18
8
5
731
22
21
15
1,642
1,316
691
596
33
29
6
6
5
5
4
5
5
5
4
1
1
1
1
2
2
693
8
5
1
1
16
16
47
14
6
57
9
20,827

Price

Date

Pages

Offers

1
5
1
2
568